Scholarlink

<p>Here we introduce FLOWR, a structure-based framework for the generation and optimization of three-dimensional ligands. FLOWR integrates continuous and categorical flow matching with equivariant optimal transport, enhanced by an efficient protein pocket conditioning. Alongside FLOWR, we present SPINDR, a curated dataset comprising ligand–pocket cocrystal complexes specifically designed to address existing data quality issues. Empirical evaluations demonstrate that FLOWR surpasses current state-of-the-art diffusion- and flow-based methods in terms of PoseBusters-validity, pose accuracy and interaction recovery, while offering an inference speed-up, achieving up to 70-fold faster performance. In addition, we introduce FLOWR.MULTI, a highly accurate multi-purpose model allowing for the targeted sampling of ligands that adhere to predefined interaction profiles and chemical substructures for fragment-based design without the need of retraining or any resampling strategies. Collectively, our results indicate that FLOWR and FLOWR.MULTI represent an advancement in artificial intelligence-driven structure-based drug design, substantially enhancing the reliability and applicability of de novo, interaction- and fragment-based ligand generation in real-world drug discovery settings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

FLOWR: flow matching for structure-aware de novo, interaction- and fragment-based ligand generation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月28日

查看全文
  • Julian Cremer,
  • Ross Irwin,
  • Alessandro Tibo,
  • Jon Paul Janet,
  • Simon Olsson,
  • Djork-Arné Clevert

摘要

Here we introduce FLOWR, a structure-based framework for the generation and optimization of three-dimensional ligands. FLOWR integrates continuous and categorical flow matching with equivariant optimal transport, enhanced by an efficient protein pocket conditioning. Alongside FLOWR, we present SPINDR, a curated dataset comprising ligand–pocket cocrystal complexes specifically designed to address existing data quality issues. Empirical evaluations demonstrate that FLOWR surpasses current state-of-the-art diffusion- and flow-based methods in terms of PoseBusters-validity, pose accuracy and interaction recovery, while offering an inference speed-up, achieving up to 70-fold faster performance. In addition, we introduce FLOWR.MULTI, a highly accurate multi-purpose model allowing for the targeted sampling of ligands that adhere to predefined interaction profiles and chemical substructures for fragment-based design without the need of retraining or any resampling strategies. Collectively, our results indicate that FLOWR and FLOWR.MULTI represent an advancement in artificial intelligence-driven structure-based drug design, substantially enhancing the reliability and applicability of de novo, interaction- and fragment-based ligand generation in real-world drug discovery settings.